Drug Trial Radar · NCT06397768
Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
2,226
Actual
Start
May 13, 2024
Primary completion
Sep 18, 2025
Study completion Sep 18, 2025
Sponsor
- Lead sponsor
- Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- May 3, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 12 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is a Phase III, randomized, single-blind, placebo-controlled, multi-center study to be conducted in healthy infants and toddlers which will be enrolled at approximately 6 months of age (Cohort 1) and approximately 12 months of age (Cohort 2). The primary objective of the study will be to assess non-inferiority of the RSV infant and toddler (RSVt) vaccine antibody response when administered concomitantly with routine pediatric vaccines at 6 months of age (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine \[Vaxelis® or Pentacel® and Recombivax HB®\] Prevnar 20®, and RotaTeq®), and 12 months of age (M-M-R II, VARIVAX, and Prevnar 20 or per local country recommendations) compared to when administered non-concomitantly.
Conditions
- RSV Immunization
Interventions
RSVt vaccineBiological
Pharmaceutical form:Liquid for nasal spray-Route of administration:Intranasal
Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccineBiological
Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular
Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccineBiological
Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular
Hepatitis B vaccineBiological
Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular
Streptococcus pneumoniae vaccineBiological
Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular
Rotavirus vaccineBiological
Pharmaceutical form:Oral solution-Route of administration:Oral
Measles, mumps, and rubella vaccineBiological
Pharmaceutical form:Lyophilized live virus for reconstitution -Route of administration:Subcutaneous or Intramuscular
Varicella virus vaccineBiological
Pharmaceutical form:Suspension for injection-Route of administration:Subcutaneous or Intramuscular
PlaceboBiological
Pharmaceutical form:Liquid for nasal spray-Route of administration:Intranasal
Primary outcomes
What the sponsor says the trial is designed to measure.
- RSV A serum neutralizing antibody titers at 28 days post dose 2 (D85) Groups 1 and 3Time frame: Day 85
- RSV B serum neutralizing antibody titers at 28 days post dose 2 (D85) Groups 1 and 3Time frame: Day 85
- RSV A serum neutralizing antibody titers at Day 113 Groups 2 and 4Time frame: Day 113
- RSV B serum neutralizing antibody titers at Day 113 Groups 2 and 4Time frame: Day 113
Locations
72 sites in 3 countries. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics - Birmingham - St. Vincent's Drive- Site Number : 8400007
Birmingham, Alabama
South Alabama Medical Clinic- Site Number : 8400065
Grand Bay, Alabama
MedPharmics - Mobile - Dauphin Street- Site Number : 8400017
Mobile, Alabama
Northwest Arkansas Pediatric Clinic- Site Number : 8400002
Fayetteville, Arkansas
Alliance Research Institute - Bell Gardens - Garfield Avenue- Site Number : 8400040
Bell Gardens, California
Matrix Clinical Research - Huntington Park- Site Number : 8400018
Huntington Park, California
Paradigm Clinical Research Centers- Site Number : 8400059
La Mesa, California
Matrix Clinical Research - Los Angeles- Site Number : 8400008
Los Angeles, California
Kaiser Permanente - Oakland Medical Center- Site Number : 8400047
Oakland, California
Stanford University Medical Center CTRU - 800 Welch Road- Site Number : 8400070
Palo Alto, California
Kaiser Permanente - Sierra Gardens- Site Number : 8400063
Roseville, California
Kaiser Permanente - Point West Medical Offices- Site Number : 8400064
Sacramento, California
Kaiser Permanente - San Jose Medical Center- Site Number : 8400060
San Jose, California
Kaiser Permanente - Santa Clara Medical Center- Site Number : 8400061
Santa Clara, California
Integrated Clinical Research LLC- Site Number : 8400036
Sherman Oaks, California
Kaiser Permanente - Walnut Creek Medical Center- Site Number : 8400062
Walnut Creek, California
Velocity Clinical Research - Washington DC- Site Number : 8400050
Washington D.C., District of Columbia
Prohealth Research Center- Site Number : 8400068
Doral, Florida
The Medici Medical Research- Site Number : 8400055
Hollywood, Florida
Dade Research Center- Site Number : 8400014
Miami, Florida
Riveldi Biomedical Research and Associates - Miami Lakes- Site Number : 8400015
Miami Lakes, Florida
SEC Clinical Research - Pensacola- Site Number : 8400034
Pensacola, Florida
PAS Research- Site Number : 8400005
Tampa, Florida
Leavitt Women's Healthcare- Site Number : 8400009
Idaho Falls, Idaho
Velocity Clinical Research - Sioux City- Site Number : 8400054
Sioux City, Iowa
Alliance for Multispeciality Research - El Dorado- Site Number : 8400019
El Dorado, Kansas
University of Kentucky Chandler Medical Center- Site Number : 8400051
Lexington, Kentucky
Velocity Clinical Research - New Orleans- Site Number : 8400058
New Orleans, Louisiana
Research Works INC- Site Number : 8400044
New Orleans, Louisiana
Velocity Clinical Research - Gulfport- Site Number : 8400011
Gulfport, Mississippi
QPS Bio-Kinetic Clinical Applications- Site Number : 8400046
Springfield, Missouri
Boeson Research - Great Falls- Site Number : 8400041
Great Falls, Montana
Boeson Research - Missoula- Site Number : 8400006
Missoula, Montana
Velocity Clinical Research - Grand Island- Site Number : 8400016
Grand Island, Nebraska
Midwest Childrens Health Research Institute- Site Number : 8400038
Lincoln, Nebraska
Velocity Clinical Research - Omaha- Site Number : 8400001
Omaha, Nebraska
PAS Research - Henderson- Site Number : 8400049
Henderson, Nevada
NYU Langone Cardiothoracic Surgery Associates - Garden City- Site Number : 8400048
Garden City, New York
Summerwood Pediatrics- Site Number : 8400021
Liverpool, New York
SUNY Upstate Medical University - Syracuse- Site Number : 8400029
Syracuse, New York
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.